These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2105245)

  • 1. Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization.
    Padilla SL; Bayati J; Garcia JE
    Fertil Steril; 1990 Feb; 53(2):288-94. PubMed ID: 2105245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value assessment of the early response of blood estradiol, FSH, and LH using leuprolide acetate during ovarian hyperstimulation in assisted reproduction].
    Sondón García Z; Alvarado A; Peraza Briones C; González Sánchez R; Jiménez Perea L
    Ginecol Obstet Mex; 2001 Feb; 69():65-71. PubMed ID: 11339176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian stimulation for in vitro fertilization using pure follicle-stimulating hormone with and without gonadotropin-releasing hormone agonist in high-responder patients.
    Edelstein MC; Brzyski RG; Jones GS; Oehninger S; Sieg SM; Muasher SJ
    J In Vitro Fert Embryo Transf; 1990 Jun; 7(3):172-6. PubMed ID: 2116488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin and estradiol levels during ovarian stimulation in women treated with leuprolide acetate.
    Stone BA; Serafini PC; Quinn K; Quinn P; Kerin JF; Marrs RP
    Obstet Gynecol; 1989 Jun; 73(6):990-5. PubMed ID: 2498795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment.
    Brzyski RG; Muasher SJ; Droesch K; Simonetti S; Jones GS; Rosenwaks Z
    Fertil Steril; 1988 Dec; 50(6):917-21. PubMed ID: 3144467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization.
    Padilla SL; Smith RD; Garcia JE
    Fertil Steril; 1991 Jul; 56(1):79-83. PubMed ID: 1906020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
    Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
    Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different regimens of a gonadotropin-releasing hormone analog during ovarian stimulation for in vitro fertilization.
    Benadiva CA; Blasco L; Tureck R; Mastroianni L; Flickinger GL
    Fertil Steril; 1990 Mar; 53(3):479-85. PubMed ID: 2106454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE; Padilla SL; Bayati J; Baramki TA
    Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization.
    Surrey ES; Bower J; Hill DM; Ramsey J; Surrey MW
    Fertil Steril; 1998 Mar; 69(3):419-24. PubMed ID: 9531870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in luteal phase progesterone and estradiol production after leuprolide acetate therapy before ovarian stimulation for in vitro fertilization.
    Brzyski RG; Jones GS; Jones HW; Oehninger S; Muasher SJ
    Fertil Steril; 1991 Jan; 55(1):119-24. PubMed ID: 1898886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome.
    Muasher SJ; Oehninger S; Simonetti S; Matta J; Ellis LM; Liu HC; Jones GS; Rosenwaks Z
    Fertil Steril; 1988 Aug; 50(2):298-307. PubMed ID: 3135206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between luteinizing hormone and estradiol secretion in female precocious puberty: evaluation by sensitive gonadotropin assays and the leuprolide stimulation test.
    Garibaldi LR; Aceto T; Weber C; Pang S
    J Clin Endocrinol Metab; 1993 Apr; 76(4):851-6. PubMed ID: 8473395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal serum progesterone and history of elevated progesterone on the day of hCG administration are significant predictors of late follicular progesterone elevation in GnRH antagonist IVF cycles.
    Venetis CA; Kolibianakis EM; Bosdou JK; Lainas GT; Sfontouris IA; Tarlatzis BC; Lainas TG
    Hum Reprod; 2016 Aug; 31(8):1859-65. PubMed ID: 27301360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete androgen and progesterone suppression following midluteal GnRHa prior to controlled ovarian hyperstimulation for IVF-ET.
    Gelety TJ; Surrey ES
    J Assist Reprod Genet; 1997 Oct; 14(9):525-30. PubMed ID: 9401871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between nafarelin and leuprolide acetate for in vitro fertilization: preliminary clinical study.
    Dantas ZN; Vicino M; Balmaceda JP; Asch RH; Stone SC
    Fertil Steril; 1994 Apr; 61(4):705-8. PubMed ID: 8150114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantation and pregnancy rates in relation to oestradiol and progesterone profiles in cycles with and without the use of gonadotrophin-releasing hormone agonist suppression.
    Hassiakos D; Toner JP; Muasher SJ; Jones HW
    Hum Reprod; 1990 Nov; 5(8):1004-8. PubMed ID: 2127937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of the initial response of serum estradiol levels to stimulation with GnRH analogues in in vitro fertilization].
    Cabra R; Muñiz M; Jaroslav Stern J; Verez JR; Gutiérrez Najar AJ
    Ginecol Obstet Mex; 1998 Jun; 66():242-7. PubMed ID: 9679400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.